Duke University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Duke University sits in the top decile of US sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count).
Duke University: 1,725 sponsored US clinical trials, 187 recruiting.
Duke University sponsors 1,725 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 1,244 completed. 175 of these trials are in Phase 3-4 (later-stage) and 311 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
Duke University ranks in the top decile of sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,244 of 1,444 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,725 total, page 15 of 35
Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD
NCT03216512
Reach Home and Read
NCT03699592
The Influence of a Cognitive Behavioral Approach on Changing Patient Expectations in Shoulder Pain
NCT03353272
Pain Perception During Vulvar Biopsy
NCT03654417
Patient- and Task-specific Radiation Dose Optimization for Pediatric Abdominopelvic CT Applications
NCT03429712
The DETOURS Trial: De-escalating Empiric Treatment: Opting Out of Rx for Selected Patients With Suspected Sepsis - Opt-Out Protocol Trial
NCT03517007
System for High-Intensity Evaluation During Radiotherapy
NCT04277650
Neuromodulatory Treatments for Pain Management in TBI
NCT03418129
Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea
NCT03351114
The Learning Registry
NCT03911284
Bedside Optical Retinal Assessment of Hypoxic Ischemic Encephalopathy in Infants
NCT03640494
Neuromodulation Therapy for Task-Specific Dystonia
NCT06422104
Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation Study
NCT03775759
Exercise Training to Promote Resilience to Chronic Lymphocytic Leukemia
NCT04950452
Quality of Life of Patients With Glioblastoma (GBM) Treated With Tumor-Treating Fields
NCT03501134
Trial Comparing PLA to HIGRT (PROVE-HCC)
NCT03402607
The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products
NCT03492463
Earplugs and Eye Masks for Reducing Delirium
NCT03471520
Reducing Disparities in the Quality of Advance Care Planning for Older Adults
NCT03516994
Comparison of Oral Anticoagulants for Extended VEnous Thromboembolism
NCT03196349
Testing the Feasibility of the DASH Cloud Intervention Using Amazon Alexa
NCT03455946
Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines
NCT03530124
Effexts OF THE Cleansweep Suction Catheter
NCT03486002
Low Dose CT Distal Radius Fractures
NCT03423043
TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure
NCT03296813
A Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR Mutations
NCT03434418
Study of ALS Reversals 2: Genetic Analyses
NCT03464903
Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer
NCT03394885
Digital Symptom Tracking, Patient Engagement and Quality of Life in GI Oncology Clinic Patients
NCT03459352
Balanced (Egg) Protein During Obesity Reduction: Differential Responses of Insulin Resistance by Race
NCT03771261
Active Recreation Through Community-Healthcare Engagement Study
NCT03246763
Preventing Post-Vaccination Presyncope and Syncope in Adolescents Using Simple, Clinic-based Interventions: A Pilot Study
NCT03533829
Collaboration to Promote Early Childhood Well Being in Families Experiencing Homelessness
NCT03530137
Gene-by-Stress Interactions in Intervention Studies Significance
NCT03011645
Project Q Pilot: Smoking Cessation for Light Smokers
NCT03416621
Early Palliative Care Intervention in Malignant Glioma
NCT03471546
Disease-Modifying Treatments for Myasthenia Gravis
NCT03490539
Evaluation of Utility of Ultrasound Guided iPACK Block for Knee Extension After Total Knee Arthroplasty.
NCT03353233
Femoral Peri-arterial Local Anesthetic Injection Decreases Tourniquet Associated Ischemic Hypertension
NCT03390426
SER Hispano Longitudinal Study
NCT03527654
Abdominal Nerve Blockade in Chronic Heart Failure.
NCT03453151
Human Gut Microbiota and Prebiotic Response
NCT03595306
REACH Implicit Bias Training Project
NCT03415308
Physical Activity in Men Newly Diagnosed With Prostate Cancer: A Feasibility Study
NCT03331458
Contributing Factors in the Pathobiology of Airway Remodeling in Obesity
NCT03115632
Metoclopramide Versus Placebo for GJ Placement
NCT03331965
Low Cost OCT for Point of Care
NCT03323307
Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075
NCT03248947
Lingual Muscle Training in Late-Onset Pompe Disease (LOPD)
NCT03255213
Bilateral Brain Dynamics in Cognition and Aging
NCT03224988
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 136 |
| Phase 2 | 175 |
| Phase 3 | 41 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Duke University pipeline
187 recruiting of 1,725 indexed (11% open); 1,244 completed (72%).
Phase mix: 175 late (III/IV) vs 311 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Duke University: open-pipeline peers nationwide
Peers matched on 1,725 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Duke University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,725 trials (± recruiting share)
- University of California, San Francisco · 1,713 trials · 16% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 11% open enrollment (± trial volume)
- Carnegie Mellon University · 11% recruiting · 37 trials
- CAMC Health System · 11% recruiting · 28 trials
- UConn Health · 11% recruiting · 178 trials
- Hartford Hospital · 11% recruiting · 75 trials
Related
What to do with this Duke University page
1,725 registered trials is a research-attention snapshot, not an endorsement of Duke University or any single study.
- 187 of Duke University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Duke University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Duke University pipeline card: 1,725 registered trials from official public datasets.Report a data error.